We previously reported that SERPINB2 (a ~ 60 kDa serine protease inhibitor) might serve as a reliable marker of toxic response to various hazardous compounds in multiple types of cancer stem cells [58] and cord blood stem cells [27]. Here, SERPINB2 is linked to cancer.